Investing

Cathie Wood's ARK Invest Buys for 11/29

blackred / E+ via Getty Images

Broad markets recovered to start out the week after the worst trading day of the year on Friday. ARK Funds took a cue from the markets and bounced back for the most part. ARKQ performed the best out of the group, with a 0.7% gain on the day, while ARKG did the worst, down 1.4%. The gains from the past year are slowly sliding away, but Cathie Wood may have something up her sleeve, as she is constantly reshuffling her ETFs to stand up to market headwinds.

ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.

Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.

While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major purchases that ARK Invest executed on November 29, 2021. Also check out all the ARK Invest sales that took place that same day.

The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here is a notable purchase in this fund: 35,477 shares of Twilio, 342,346 shares of Robinhood, & 62,220 shares of Discovery.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. The biggest holdings are Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable buys in this fund: 112,100 shares of Surface Oncology, 116,488 shares of Schrodinger, 123,471 shares of 1Life Healthcare, & 29,252 shares of Adaptive Bio.

ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable purchases in this fund: 62,409 shares of Trimble, 419,669 shares of Pacific Bio, & 572,717 shares of Robinhood.

ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused, unsurprisingly, on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. Big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are some notable purchases in the fund: 102,325 shares of Blade Air Mobility, 119,451 shares of Markforged, & 475,825 shares of Palantir.

ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. Some names in this fund are similar to the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are some notable purchases in the fund: 367,949 shares of Nano Dimension & 45,574 shares of Veracyte.

Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is focused primarily on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. Notable trades in the fund: 60,285 shares of Iridium Communications.

Check out all the buys here:

FUND Direction Ticker Name Shares
ARKF Buy DSYFP DASSAULT SYSTEMES SE 62,220
ARKF Buy TWLO TWILIO INC 35,477
ARKF Buy TDOC TELADOC HEALTH INC 1,400
ARKF Buy HOOD ROBINHOOD MARKETS INC 342,346
ARKF Buy DSYSJ DISCOVERY LTD 62,220
ARKG Buy TDOC TELADOC HEALTH INC 2,650
ARKG Buy SURF SURFACE ONCOLOGY INC 112,100
ARKG Buy SGFY SIGNIFY HEALTH INC 56,672
ARKG Buy SDGR SCHRODINGER INC/UNITED STATES 116,488
ARKG Buy ONEM 1LIFE HEALTHCARE INC 123,471
ARKG Buy MASS 908 DEVICES INC 7,800
ARKG Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 29,252
ARKK Buy TRMB TRIMBLE INC 62,409
ARKK Buy TDOC TELADOC HEALTH INC 8,800
ARKK Buy PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 419,669
ARKK Buy MTLS MATERIALISE NV 22,287
ARKK Buy HOOD ROBINHOOD MARKETS INC 572,717
ARKQ Buy ACHR ARCHER AVIATION INC 34,547
ARKQ Buy BLDE BLADE AIR MOBILITY INC 102,325
ARKQ Buy BYDDY BYD CO LTD 29,094
ARKQ Buy MKFG MARKFORGED HOLDING CORP 119,451
ARKQ Buy PLTR PALANTIR TECHNOLOGIES INC 475,825
ARKQ Buy VLD VELO3D INC 167,644
ARKW Buy CND CONCORD ACQUISITION CORP 74,475
ARKW Buy NNDM NANO DIMENSION LTD 367,949
ARKW Buy TDOC TELADOC HEALTH INC 2,300
ARKW Buy VCYT VERACYTE INC 45,574
ARKX Buy IRDM IRIDIUM COMMUNICATIONS INC 60,285

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.

Credit Card Companies Are Doing Something Nuts

Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.

It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.

We’ve assembled some of the best credit cards for users today.  Don’t miss these offers because they won’t be this good forever.

 

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.